No black box warning on record for Griseofulvin Microsize

As of the latest FDA labeling reviewed, Griseofulvin Microsize (GRISEOFULVIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Griseofulvin Microsize medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Prophylactic Usage Safety and efficacy of griseofulvin for prophylaxis of fungal infections have not been established. Serious Skin Reactions Severe skin reactions (e.g. Stevens-Johnson syndrome, toxic epidermal necrolysis) and erythema multiforme have been reported with griseofulvin use. These reactions may be serious and may result in hospitalization or death. If severe skin reactions o

No black box warning on record for Griseofulvin Microsize

Other warnings & precautions

WARNINGS Prophylactic Usage Safety and efficacy of griseofulvin for prophylaxis of fungal infections have not been established. Serious Skin Reactions Severe skin reactions (e.g. Stevens-Johnson syndrome, toxic epidermal necrolysis) and erythema multiforme have been reported with griseofulvin use. These reactions may be serious and may result in hospitalization or death. If severe skin reactions o

Griseofulvin Microsize Black Box Warning

No black box warning on record for Griseofulvin Microsize

Other warnings & precautions

Griseofulvin Microsize Black Box Warning

No black box warning on record for Griseofulvin Microsize

Other warnings & precautions